Atria Wealth Solutions, Inc. Aspira Women'S Health Inc. Transaction History

Atria Wealth Solutions, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Aug 22, 2023	BUY	$0.32 - $0.58 $11,360 - $20,590	35,500 New	35,500 $13,000
Q1 2023 Jun 14, 2023	BUY	$0.32 - $0.58 $1,584 - $2,871	4,951 Added 13.95%	40,451 $14,000
Q1 2023 May 10, 2023	SELL	$0.32 - $0.58 $1,584 - $2,871	-4,951 Reduced 12.24%	35,500 $13,000
Q4 2022 Aug 30, 2023	BUY	$0.3 - $0.41 $12,135 - $16,584	40,451 New	40,451 $13,000
Q4 2022 Feb 13, 2023	SELL	$0.3 - $0.41 $8,010 - $10,947	-26,700 Reduced 39.76%	40,451 $13,000
Q2 2022 Aug 15, 2022	BUY	$0.4 - $1.09 $7,960 - $21,691	19,900 Added 42.12%	67,151 $39,000
Q1 2022 May 16, 2022	BUY	$0.88 - $1.81 $41,580 - $85,524	47,251 New	47,251 $49,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of Atria Wealth Solutions, Inc., based on Form 13F filings with the SEC.

Stay updated on Atria Wealth Solutions, Inc. with notifications on news.